The effects of alcohol consumption on mortality and morbidity: a 26-year follow-up study.

2001 ◽  
Vol 62 (6) ◽  
pp. 783-789 ◽  
Author(s):  
H Theobald ◽  
S E Johansson ◽  
L O Bygren ◽  
P Engfeldt
Keyword(s):  
Alcohol Consumption ◽  
Mortality And Morbidity ◽  
Follow Up Study

scholarly journals Association between the incidence of hypertension and alcohol consumption pattern and the alcohol flushing response: A 12-year follow-up study

Alcohol ◽  
2020 ◽  
Vol 89 ◽  
pp. 43-48
Author(s):  
Min-Gyu Yoo ◽  
Yoo Jeong Lee ◽  
Han Byul Jang ◽  
Hyo-Jin Kim ◽  
Hye-Ja Lee ◽  
...  
Keyword(s):  
Alcohol Consumption ◽  
Consumption Pattern ◽  
Follow Up Study ◽  
Alcohol Flushing

scholarly journals Mortality and morbidity of proximal femur fractures in elderly population – A three year follow-up study

2020 ◽  
Vol 6 (2) ◽  
pp. 69-72
Author(s):  
Sandeep Krishna Avulapati ◽  
◽  
Avinash Bajjuri ◽  
Sunil Boddu ◽  
Anudeep Peddineni ◽  
...  
Keyword(s):  
Proximal Femur ◽  
Elderly Population ◽  
Mortality And Morbidity ◽  
Proximal Femur Fractures ◽  
Follow Up Study ◽  
Femur Fractures

scholarly journals Long-term outcome of profound hyponatremia: a prospective 12 months follow-up study

2016 ◽  
Vol 175 (6) ◽  
pp. 499-507 ◽  
Author(s):  
Bettina Winzeler ◽  
Nica Jeanloz ◽  
Nicole Nigro ◽  
Isabelle Suter-Widmer ◽  
Philipp Schuetz ◽  
...  
Keyword(s):  
Sodium Level ◽  
Medical Condition ◽  
Tertiary Care ◽  
Drug Induced ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Mortality And Morbidity ◽  
Follow Up Study

Background Hyponatremia is the most common electrolyte abnormality in hospitalized patients and given its impact on mortality and morbidity, a relevant medical condition. Nevertheless, little is known about factors influencing long-term outcome. Methods This is a prospective observational 12-month follow-up study of patients with profound hyponatremia (≤125 mmol/L) admitted to the emergency department of two tertiary care centers between 2011 and 2013. We analyzed the predictive value of clinical and laboratory parameters regarding the following outcomes: 1-year mortality, rehospitalization and recurrent profound hyponatremia. Results Median (IQR) initial serum sodium (s-sodium) level of 281 included patients was 120 mmol/L (116–123). During the follow-up period, 58 (20.6%) patients died. The majority (56.2%) were rehospitalized at least once. Recurrent hyponatremia was observed in 42.7%, being profound in 16%. Underlying comorbidities, assessed by the Charlson Comorbidity Index, predicted 1-year mortality (odds ratio (OR) 1.43, 95% confidence interval (CI) 1.25–1.64, P < 0.001). Furthermore, ‘s-sodium level at admission’ (OR 1.14, 95% CI 1.01–1.29, P = 0.036) and ‘correction of hyponatremia’ defined as s-sodium ≥135 mmol/L at discharge were associated with mortality (OR 0.47, 95% CI 0.23–0.94, P = 0.034). Mortality rate fell with decreasing baseline s-sodium levels and was lower in the hyponatremia category ≤120 mmol/L vs >120 mmol/L (14.8% and 27.8%, P < 0.01). Patients with s-sodium level ≤120 mmol/L were more likely to have drug-induced hyponatremia, whereas hypervolemic hyponatremia was more common in patients with s-sodium >120 mmol/L. Conclusion Hyponatremia is associated with a substantial 1-year mortality, recurrence and rehospitalization rate. The positive correlation of s-sodium and mortality emphasizes the importance of the underlying disease, which determines the outcome besides hyponatremia itself.

A 2-year follow-up study of alcohol consumption and risk of dementia

2006 ◽  
Vol 108 (4) ◽  
pp. 378-383 ◽  
Author(s):  
Juan Deng ◽  
David H.D. Zhou ◽  
Jingcheng Li ◽  
Y. John Wang ◽  
Changyue Gao ◽  
...  
Keyword(s):  
Alcohol Consumption ◽  
Follow Up Study

Association of adolescent catatonia with increased mortality and morbidity: Evidence from a prospective follow-up study

2009 ◽  
Vol 113 (2-3) ◽  
pp. 233-240 ◽  
Author(s):  
Françoise Cornic ◽  
Angèle Consoli ◽  
Marie-Laure Tanguy ◽  
Olivier Bonnot ◽  
Didier Périsse ◽  
...  
Keyword(s):  
Mortality And Morbidity ◽  
Follow Up Study

Disulfiram Treatment of Alcoholism

1992 ◽  
Vol 161 (1) ◽  
pp. 84-89 ◽  
Author(s):  
Jonathan Chick ◽  
Kevin Gough ◽  
Wojciech Falkowski ◽  
Peter Kershaw ◽  
Brian Hore ◽  
...  
Keyword(s):  
Treatment Outcome ◽  
Alcohol Consumption ◽  
Vitamin C ◽  
Adverse Reactions ◽  
Treatment Withdrawal ◽  
Patient Treatment ◽  
Follow Up Study ◽  
Weekly Alcohol Consumption ◽  
Group Serum

To assess the efficacy of supervised disulfiram as an adjunct to out-patient treatment of alcoholics, a randomised, partially blind, six-month follow-up study was conducted in which 126 patients received 200 mg disulfiram or 100 mg vitamin C under the supervision of a nominated informant. In the opinion of the (blinded) independent assessor, patients on disulfiram increased average total abstinent days by 100 and patients on vitamin C by 69, thus enhancing by one-third this measure of treatment outcome. Mean weekly alcohol consumption was reduced by 162 units with disulfiram, compared with 105 units with vitamin C., and the disulfiram patients reduced their total six-month alcohol consumption by 2572 units compared with an average reduction of 1448 units in the vitamin C group. Serum gamma-GT showed a mean fall of 21 IU/I in patients on disulfiram but rose by a mean of 13 IU/I with vitamin C. Unwanted effects in the disulfiram group led to a dose reduction in seven patients and to treatment withdrawal in four (and in one vitamin C patient). Two-thirds of the disulfiram group asked to continue the treatment at the end of the study. There were no medically serious adverse reactions.

Sign in / Sign up

Export Citation Format

Share Document